Analysis of clinical characteristics of tislelizumab-induced Stevens-Johnson syndrome/toxic epidermal necrolysis in the Chinese population: a systematic review
This indicates that tislelizumab-related SJS/TEN mostly occurs days to months after treatment. Clinical practice should strengthen the evaluation and monitoring of early cutaneous adverse reactions, with timely detection and intervention to ensure safe medication use for patients.
Authors
- Xiuling Wen (ORCID: https://orcid.org/0000-0002-9796-5612)
- W. B. Li
- Qinghua Zhang (ORCID: https://orcid.org/0000-0001-9086-7000)
Institutions
- Guangzhou University of Chinese Medicine (CN)
- Nanfang Hospital (CN)
- Jiangmen Central Hospital (CN)
Publication Details
- Journal
- Cutaneous and Ocular Toxicology
- Published
- 2025-11-21
- DOI
- https://doi.org/10.1080/15569527.2025.2588769
- Primary Topic
- Drug-Induced Adverse Reactions
- Type
- article
- Field-Weighted Citation Impact
- 0.00